Description: Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, and Wellcome. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
Home Page: kinetabio.com
KA Technical Analysis
219 Terry Ave. N
Seattle,
WA
98109
United States
Phone:
206 378 0400
Officers
| Name | Title |
|---|---|
| Mr. Craig W. Philips | President & Secretary |
| Mr. Keith A. Baker | Chief Financial Officer |
| Dr. Thierry Guillaudeux Ph.D. | Chief Scientific Officer |
| Mr. Gary Gentges | Executive Vice President of Corporate Development |
| Ms. Pauline Kenny Esq., J.D. | Advisor |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 9.6506 |
| Price-to-Sales TTM: | 1.4373 |
| IPO Date: | 2016-02-11 |
| Fiscal Year End: | December |
| Full Time Employees: | 11 |